PHILIP MASON

Summary

Affiliation: Washington University School of Medicine
Country: USA

Publications

  1. ncbi Expression of Plasmodium falciparum G6PD-6PGL in laboratory parasites and in patient isolates in G6PD-deficient and normal Nigerian children
    Olugbemiro Sodeinde
    Department of Haematology, Division of Investigative Science, Faculty of Medicine, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, UK
    Br J Haematol 122:662-8. 2003
  2. ncbi G6PD deficiency: the genotype-phenotype association
    Philip J Mason
    Division of Hematology, Department of Internal Medicine, Washington University School of Medicine, Campus Box 8125, 660 South Euclid Avenue, St Louis, MO 63110, USA
    Blood Rev 21:267-83. 2007
  3. ncbi Heterozygous telomerase deficiency in mouse and man: when less is definitely not more
    Philip J Mason
    Division of Hematology, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Cell Cycle 3:1127-9. 2004
  4. ncbi Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome
    Joshua J Field
    Department of Pathology, Washington University School of Medicine, St Louis, MO 63110, USA
    J Pediatr Hematol Oncol 28:450-3. 2006
  5. ncbi Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome
    Hong yan DU
    Department of Internal Medicine, Washington Uiversity School of Medicine, 660 S Euclid Avenue, St Louis, MO 63110, USA
    Aging Cell 6:689-97. 2007
  6. ncbi Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features suggestive of dyskeratosis congenita and IMAGe association
    Sharon McDonald
    Department of Pediatrics, Washington University School of Medicine, St Louis Children s Hospital, St Louis, MO 63110, USA
    Pediatr Blood Cancer 54:154-7. 2010
  7. ncbi Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing
    Yuko Mochizuki
    Department of Internal Medicine, Division of Hematology, Washington University School of Medicine, St Louis, MO 63110, USA
    Proc Natl Acad Sci U S A 101:10756-61. 2004
  8. ncbi Dyskeratosis congenita and telomerase
    Monica Bessler
    Division of Hematology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Curr Opin Pediatr 16:23-8. 2004
  9. ncbi A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice
    Bai Wei Gu
    Department of Medicine, Division of Hematology, Washington University School of Medicine, St Louis, MO 63110, USA
    Proc Natl Acad Sci U S A 105:10173-8. 2008
  10. ncbi TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements
    Hong yan DU
    Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Blood 113:309-16. 2009

Research Grants

  1. The Pathogenesis of Dyskeratosis Congenita
    PHILIP MASON; Fiscal Year: 2009

Collaborators

  • Lea Harrington
  • Tom Vulliamy
  • Anna Marrone
  • An Ping
  • Joshua J Field
  • Monica Bessler
  • Inderjeet Dokal
  • Shalini Shenoy
  • Jeffrey Lipton
  • T Ferkol
  • Tobias Else
  • Sharon McDonald
  • DAVID RUDNICK
  • Suely M Rezende
  • Seyed A Mesbah-Namin
  • Olugbemiro Sodeinde
  • Perrin White
  • Steven Artandi
  • Hong yan DU
  • Jingping Ge
  • Jun He
  • Bai Wei Gu
  • David B Wilson
  • Julia L Clarke
  • Hong-Yan Du
  • Yuko Mochizuki
  • Baiwei Gu
  • Elena Pumbo
  • Andrew S Venteicher
  • Ping An
  • Jennifer Ivanovich
  • Sara Robledo
  • Quillan Huang
  • Almudena Crooke
  • Arturo Londono-Vallejo
  • Fred Goldman
  • Shashikant Kulkarni
  • Jose M Bautista
  • Blandine Mille-Baker
  • Nicole Draper
  • Robin van Bruggen
  • Seth D Crosby
  • Michael E Heinz
  • Dan L Crimmins
  • Jack H Ladenson
  • Chunjun Zhao
  • Jian Meng Fan
  • Richard T Maziarz
  • Adrianna Vlachos
  • Deborah Chirnomas
  • Ulrike M Reiss
  • Akiko Shimamura
  • Qing Dai
  • Frederick Goldman
  • Rakesh K Goyal
  • Zhaojing Meng
  • Timothy D Veenstra
  • Susan J Bayliss
  • Peter Manley
  • Bai-Wei Gu
  • Rachel Idol
  • Amalia Diez
  • Rachida Bouarich
  • Sara Freeman
  • Oliver Bedendo
  • Michael A Laffan
  • Wiebke Arlt
  • David A Lane
  • Paula H Bolton-Maggs
  • Cedric H L Shackleton
  • Elizabeth A Walker
  • Ian Laing
  • Iwona J Bujalska
  • David W Ray
  • Susan M Chalder
  • Gareth G Lavery
  • David Roper
  • Martin Hewison
  • D Mark Layton
  • James I Walker
  • Jeremy W Tomlinson
  • Paul M Stewart
  • Rachel E Simmonds
  • John M Connell
  • Andrew M Will
  • Ewa Malunowicz
  • Barbara J Wild
  • Sandra Navarrete
  • Rob van Zwieten
  • David Stevens

Detail Information

Publications35

  1. ncbi Expression of Plasmodium falciparum G6PD-6PGL in laboratory parasites and in patient isolates in G6PD-deficient and normal Nigerian children
    Olugbemiro Sodeinde
    Department of Haematology, Division of Investigative Science, Faculty of Medicine, Imperial College School of Medicine, Hammersmith Hospital, London W12 0NN, UK
    Br J Haematol 122:662-8. 2003
    ....
  2. ncbi G6PD deficiency: the genotype-phenotype association
    Philip J Mason
    Division of Hematology, Department of Internal Medicine, Washington University School of Medicine, Campus Box 8125, 660 South Euclid Avenue, St Louis, MO 63110, USA
    Blood Rev 21:267-83. 2007
    ..The severe mutations mostly affect residues at the dimer interface or those that interact with a structural NADP molecule that stabilizes the enzyme...
  3. ncbi Heterozygous telomerase deficiency in mouse and man: when less is definitely not more
    Philip J Mason
    Division of Hematology, Department of Internal Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Cell Cycle 3:1127-9. 2004
    ..Here we review several scenarios in which telomerase levels are disturbed, in human diseases or following genetic manipulation in mice...
  4. ncbi Low frequency of telomerase RNA mutations among children with aplastic anemia or myelodysplastic syndrome
    Joshua J Field
    Department of Pathology, Washington University School of Medicine, St Louis, MO 63110, USA
    J Pediatr Hematol Oncol 28:450-3. 2006
    ..Screening for TERC gene mutations is unlikely to diagnose occult DC in children with severe bone marrow failure who require a hematopoietic stem cell transplant...
  5. ncbi Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome
    Hong yan DU
    Department of Internal Medicine, Washington Uiversity School of Medicine, 660 S Euclid Avenue, St Louis, MO 63110, USA
    Aging Cell 6:689-97. 2007
    ..However, our results suggest that several generations of TERT haploinsufficiency are needed to produce the very short telomeres seen in patients with DC...
  6. ncbi Acquired monosomy 7 myelodysplastic syndrome in a child with clinical features suggestive of dyskeratosis congenita and IMAGe association
    Sharon McDonald
    Department of Pediatrics, Washington University School of Medicine, St Louis Children s Hospital, St Louis, MO 63110, USA
    Pediatr Blood Cancer 54:154-7. 2010
    ..We considered the possibility that this patient has a defect in telomere function resulting in features of both DC and IMAGe association...
  7. ncbi Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing
    Yuko Mochizuki
    Department of Internal Medicine, Division of Hematology, Washington University School of Medicine, St Louis, MO 63110, USA
    Proc Natl Acad Sci U S A 101:10756-61. 2004
    ..Hence, our findings show that point mutations in dyskerin may affect both the telomerase and pseudouridylation pathways and the extent to which these functions are altered can vary for different mutations...
  8. ncbi Dyskeratosis congenita and telomerase
    Monica Bessler
    Division of Hematology, Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA
    Curr Opin Pediatr 16:23-8. 2004
    ..This review highlights recent research on dyskeratosis congenita and its relevance to other fields, including cancer and aging...
  9. ncbi A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice
    Bai Wei Gu
    Department of Medicine, Division of Hematology, Washington University School of Medicine, St Louis, MO 63110, USA
    Proc Natl Acad Sci U S A 105:10173-8. 2008
    ..Thus, dyskerin interacts with telomerase and affects telomere maintenance independently of telomere length...
  10. ncbi TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements
    Hong yan DU
    Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Blood 113:309-16. 2009
    ..We conclude that in the setting of BMF, measurement of telomere length is a sensitive but nonspecific screening method for DC. In the absence of BMF, telomere length measurements should be interpreted with caution...
  11. ncbi Targeted disruption of Dkc1, the gene mutated in X-linked dyskeratosis congenita, causes embryonic lethality in mice
    Jun He
    Department of Internal Medicine, Div Hematology, Washington University School of Medicine, St Louis, Missouri, MO 63110, USA
    Oncogene 21:7740-4. 2002
    ..Since mice with no telomerase are viable in the first generations the lethality we observe is unlikely to be due to the effects of mutated dyskerin on telomerase activity...
  12. ncbi Variable expression of Dkc1 mutations in mice
    Jun He
    Department of Medicine, Division of Hematology, Washington University School of Medicine, St Louis, MO 63110, USA
    Genesis 47:366-73. 2009
    ..Expression of RNA and protein was reduced compared to wild type animals, but no abnormalities of growth and development or in blood values were found in mutant mice. Thus Dkc1 mutations have variable expression in mice, as in humans...
  13. ncbi Dyskerin, telomerase and the DNA damage response
    Baiwei Gu
    Division of Hematology, Department of Medicine, Washington University School of Medicine, 660 S Euclid Avenue, St Louis, MO 63110, USA
    Cell Cycle 8:6-10. 2009
    ..Here we discuss these results in terms of the role of dyskerin in telomere maintenance and the possible role that the DNA damage response plays in the pathogenesis of DC...
  14. ncbi Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene
    Hong yan DU
    Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Blood 111:1128-30. 2008
    ..Thus in these families the expression of both TERT alleles and the inherited telomere length contribute to the clinical phenotype...
  15. ncbi Dyskeratosis congenita
    Monica Bessler
    Division of Hematology, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    FEBS Lett 584:3831-8. 2010
    ..The degree of telomere dysfunction is the major determinant of disease onset and manifestations...
  16. ncbi Anomalous electrophoretic migration of newly synthesized ribosomal RNAs and their precursors from cells with DKC1 mutations
    Bai Wei Gu
    Division of Hematology, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    FEBS Lett 583:3086-90. 2009
    ..The anomalously migrating RNA is turned over rapidly. Analysis of ribosomal RNA in these cells suggests the altered mobility is due to inefficient pseudouridylation...
  17. ncbi Dyskerin ablation in mouse liver inhibits rRNA processing and cell division
    Jingping Ge
    Division Hematology, Department Internal Medicine, Washington University School of Medicine, 660 S Euclid Ave, Box 8125, St Louis, MO 63110, USA
    Mol Cell Biol 30:413-22. 2010
    ..We conclude that hepatocytes can survive without dyskerin but that the role of dyskerin in RNA modification is essential for cellular proliferation...
  18. ncbi SnoRNA microarray analysis reveals changes in H/ACA and C/D RNA levels caused by dyskerin ablation in mouse liver
    Jingping Ge
    Division of Hematology, Department of Medicine, Washington University School of Medicine, St Louis, MO 63110, USA
    Biochem J 429:33-41. 2010
    ..The increase in C/D snoRNAs corresponded with an increase in the abundance of the mRNAs transcribed from snoRNA host genes, suggesting the increase may be part of a cellular response to defective ribosome synthesis...
  19. ncbi Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly
    Andrew S Venteicher
    Department of Medicine, Stanford School of Medicine, Stanford, CA 94305, USA
    Cell 132:945-57. 2008
    ..These findings reveal an unanticipated requirement for additional enzymes in telomerase biogenesis and suggest alternative approaches for inhibiting telomerase in cancer...
  20. ncbi Dysfunctional telomeres and dyskeratosis congenita
    Monica Bessler
    Haematologica 92:1009-12. 2007
  21. ncbi Three major glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in Mazandaran state of Iran
    Seyed A Mesbah-Namin
    Department of Biochemistry, School of Medical Sciences, Tarbiat Modarres University, PO Box 14115 331, Tehran, I R Iran
    Br J Haematol 117:763-4. 2002
    ..In addition, the distribution of these G6PD variants is more similar to that found in an Italian population than in other Middle Eastern countries...
  22. ncbi Stem cells, telomerase and dyskeratosis congenita
    Philip J Mason
    Department of Haematology-Division of Investigative Science, Faculty of Medicine, Imperial College of Science Technology and Medicine, The Hammersmith Hospital, DuCane Road, London W12 ONN, UK
    Bioessays 25:126-33. 2003
    ..Because of the importance of telomerase in tumour formation and aging, study of this disease may provide important clues about these fundamental processes...
  23. ncbi Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC
    Tom Vulliamy
    Department of Haematology, Division of Investigative Science, Imperial College London, Hammersmith Hospital, DuCane Rd, London W12 ONN, UK
    Nat Genet 36:447-9. 2004
    ..Here we show that disease anticipation is observed in families with this disease and that this is associated with progressive telomere shortening...
  24. ncbi Heterozygous telomerase RNA mutations found in dyskeratosis congenita and aplastic anemia reduce telomerase activity via haploinsufficiency
    Anna Marrone
    Department of Haematology, Division of Investigative Science, Imperial College London, Hammersmith Hospital, London, United Kingdom
    Blood 104:3936-42. 2004
    ..Finally, experiments reconstituting telomerase with both normal and mutant TERC molecules suggest the mutations act via haploinsufficiency rather than by a dominant-negative mechanism...
  25. ncbi Deletion of leucine 61 in glucose-6-phosphate dehydrogenase leads to chronic nonspherocytic anemia, granulocyte dysfunction, and increased susceptibility to infections
    Robin van Bruggen
    Central Laboratory of the Netherlands Blood Transfusion Service CLB, Amsterdam, The Netherlands
    Blood 100:1026-30. 2002
    ..Furthermore, we found that the messenger RNA of G6PD(180-182delTCT) is unstable, which may contribute to the severe G6PD deficiency observed in these patients. We propose the name "G6PD Amsterdam" for this new variant...
  26. ncbi The effect of TERC haploinsufficiency on the inheritance of telomere length
    Fred Goldman
    Department of Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA
    Proc Natl Acad Sci U S A 102:17119-24. 2005
    ..Thus, the number of cells with excessively short telomeres and the degree of residual telomerase activity may determine the onset of disease in patients with AD DC...
  27. ncbi Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation
    Tom J Vulliamy
    Department of Haematology, Hammersmith Hospital, Du Cane Rd, London, W12 ONN, United Kingdom
    Blood 107:2680-5. 2006
    ..This study highlights the considerable genetic and phenotypic diversity of DC...
  28. ncbi Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcome
    Julia L Clarke
    Department of Haematology, Faculty of Medicine, Imperial College of Science Technology and Medicine, Hammersmith Hospital, London, UK
    Blood Cells Mol Dis 30:258-63. 2003
    ..This study suggests that the metabolic consequences of a combined deficiency of GPI and G6PD might be responsible for a different clinical outcome than predicted for either defect in isolation...
  29. ncbi Deletion or replacement of the second EGF-like domain of protein S results in loss of APC cofactor activity
    Blandine Mille-Baker
    Department of Haematology, Faculty of Medicine, Imperial College, Hammersmith Hospital, London, United Kingdom
    Blood 101:1416-8. 2003
    ..We confirmed that the variant 134 had a functional gamma-carboxyglutamic acid (Gla) domain and that EGF1 was correctly folded. This is the first clear evidence that EGF2 is required for the expression of PS activity...
  30. ncbi Association between aplastic anaemia and mutations in telomerase RNA
    Tom Vulliamy
    Department of Haematology, Division of Investigative Science, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London W12 0NN, UK
    Lancet 359:2168-70. 2002
    ..027). These data indicate that, in a subset of patients with aplastic anaemia, the disorder might be associated with a genetic lesion in the telomere maintenance pathway...
  31. ncbi A unique insertion in Plasmodium berghei glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase: evolutionary and functional studies
    Julia L Clarke
    Department of Haematology, Faculty of Medicine, Imperial College of Science Technology and Medicine, Hammersmith Hospital, London W12 0NN, UK
    Mol Biochem Parasitol 127:1-8. 2003
    ..falciparum restores some of the G6PD activity and also enhances 6PGL activity. We conclude that although the insertions are evolving rapidly they have an essential role in the activity of the bifunctional enzyme...
  32. ncbi Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency
    Nicole Draper
    Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK
    Nat Genet 34:434-9. 2003
    ..CRD defines a new ER-specific redox potential and establishes H6PDH as a potential factor in the pathogenesis of PCOS...
  33. ncbi Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure
    Tom J Vulliamy
    Department of Haematology, Division of Investigative Science, Imperial College London, Hammersmith Hospital, London W12 ONN, UK
    Blood Cells Mol Dis 34:257-63. 2005
    ..These are the first natural mutations of TERT to be described and we highlight their possible pathogenic role in the development of bone marrow failure...
  34. ncbi A four base pair insertion in exon 1 of the RPS19 gene is a common polymorphism in African-Americans
    Quillan Huang
    Br J Haematol 135:745-6. 2006
  35. ncbi Transient silencing of Plasmodium falciparum bifunctional glucose-6-phosphate dehydrogenase- 6-phosphogluconolactonase
    Almudena Crooke
    Department of Biochemistry and Molecular Biology IV, Universidad Complutense de Madrid, Facultad de Veterinaria, Madrid, Spain
    FEBS J 273:1537-46. 2006
    ..The different characteristics of G6PD-6PGL with respect to its homologue in the host make it an ideal target for therapeutic strategies...

Research Grants4

  1. The Pathogenesis of Dyskeratosis Congenita
    PHILIP MASON; Fiscal Year: 2009
    ..abstract_text> ..